Last 7 days
3.6%
Last 30 days
6.7%
Last 90 days
22.7%
Trailing 12 Months
1.6%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-14 | Herzog David L | acquired | 3,032 | 65.93 | 46.00 | - |
2023-09-14 | GRISE CHERYL W | acquired | 39,096 | 65.93 | 593 | - |
2023-09-14 | KELLY EDWARD J III | acquired | 16,086 | 65.93 | 244 | - |
2023-09-14 | Johnson Jeh C. | acquired | 923 | 65.93 | 14.00 | - |
2023-09-14 | MCKENZIE DIANA | acquired | 8,439 | 65.93 | 128 | - |
2023-09-14 | HASSELL GERALD L | acquired | 9,823 | 65.93 | 149 | - |
2023-09-14 | Kinney Catherine R | acquired | 18,658 | 65.93 | 283 | - |
2023-09-14 | HUBBARD ROBERT GLENN | acquired | 41,272 | 65.93 | 626 | - |
2023-09-14 | Kennard William E | acquired | 18,987 | 65.93 | 288 | - |
2023-08-31 | TADROS RAMY | acquired | - | - | 7,894 | president, u.s. business |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-19 | BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL | reduced | -17.19 | -420,757 | 1,769,950 | 0.74% |
2023-09-13 | CGC Financial Services, LLC | new | - | 6,444 | 6,444 | -% |
2023-09-12 | Farther Finance Advisors, LLC | reduced | -9.98 | -9,091 | 65,739 | 0.01% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | unchanged | - | -826 | 33,127 | 0.01% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 92,822 | 92,822 | -% |
2023-09-01 | Portside Wealth Group, LLC | new | - | 735,817 | 735,817 | 0.14% |
2023-08-29 | Garde Capital, Inc. | new | - | 460,000 | 460,000 | 0.04% |
2023-08-24 | Alberta Investment Management Corp | unchanged | - | -58,374 | 2,340,340 | 0.02% |
2023-08-23 | Rehmann Capital Advisory Group | reduced | -4.6 | -57,996 | 780,357 | 0.07% |
2023-08-23 | Stonebridge Capital Advisors LLC | added | 26.09 | 7,887 | 42,323 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Aug 04, 2023 | board of directors of metlife inc | 16.0% | 120,043,226 | SC 13D/A | |
May 04, 2023 | board of directors of metlife inc | 15.9% | 121,521,424 | SC 13D/A | |
Feb 23, 2023 | board of directors of metlife inc | 15.9% | 122,923,807 | SC 13D/A | |
Feb 14, 2023 | dodge & cox | 6.8% | 53,583,210 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 7.08% | 55,519,588 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.1% | 55,514,415 | SC 13G/A | |
May 05, 2022 | board of directors of metlife inc | 15.6% | 127,128,424 | SC 13D/A | |
Feb 14, 2022 | dodge & cox | 7.0% | 58,725,183 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 6.77% | 56,951,725 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 8.5% | 71,686,373 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 18, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 05, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MET | 50.0B | 70.6B | 6.68% | 1.60% | 22.49 | 0.71 | 4.01% | -58.32% |
PRU | 38.7B | 64.4B | 8.46% | 7.56% | 125.56 | 0.61 | 4.97% | -6.22% |
TRV | 38.7B | 38.7B | 4.54% | 6.04% | 17.31 | 1 | 8.33% | -37.32% |
RE | 25.2B | 13.3B | 0.67% | 24.34% | 20.79 | 1.9 | 12.64% | 55.58% |
GL | 11.7B | 5.3B | -1.65% | 6.99% | 17.51 | 2.22 | 1.78% | -46.10% |
ATH | - | 22.8B | - | - | - | - | 34.59% | 179.04% |
MID-CAP | ||||||||
PRI | 7.2B | 2.7B | -0.13% | 55.74% | 15.98 | 2.64 | -1.39% | 16.12% |
LNC | 4.4B | 15.3B | 0.50% | -43.85% | -3.31 | 0.29 | -26.53% | -139.84% |
AEL | 4.2B | 2.7B | 2.00% | 43.46% | 3.53 | 1.58 | 38.34% | -32.53% |
BHF | 3.4B | 1.9B | 7.96% | 5.39% | 2.13 | 1.8 | -77.15% | -71.29% |
GNW | 2.7B | 7.5B | 3.00% | 49.36% | 5.07 | 0.36 | -1.40% | -38.58% |
SMALL-CAP | ||||||||
VERY | 81.1M | 171.0M | -2.50% | -17.43% | -6.56 | 0.47 | -0.92% | 29.17% |
AAME | 39.9M | 187.0M | 2.62% | -36.73% | 60.43 | 0.21 | -4.23% | -77.34% |
7.8%
10.9%
9.6%
21.5%
49.2%
27.3%
18.9%
Y-axis is the maximum loss one would have experienced if Metlife was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 1.7% | 70,597 | 69,448 | 69,898 | 73,238 | 67,873 | 70,923 | 71,080 | 70,409 | 69,519 | 65,094 | 67,842 | 65,567 | 68,230 | 71,628 | 69,620 | 68,139 | 65,750 | 69,438 | 67,941 | 68,119 | 68,001 |
Operating Expenses | 1.9% | 12,121 | 11,896 | 12,034 | 11,854 | 12,415 | 12,388 | 12,586 | 12,739 | 12,925 | 13,027 | 13,150 | 13,357 | 13,330 | 13,737 | 13,689 | 13,453 | 13,479 | 13,574 | 13,714 | 14,071 | 13,920 |
EBITDA | -100.0% | - | 3,339 | 3,764 | 3,337 | 4,970 | 9,461 | 9,040 | 7,902 | 6,770 | 2,483 | 7,818 | 7,314 | 9,166 | 11,338 | 7,451 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.05* | 0.05* | 0.05* | 0.07* | 0.13* | 0.13* | 0.11* | 0.10* | 0.04* | 0.12* | 0.11* | 0.13* | 0.16* | 0.11* | - | - | - | - | - | - |
Interest Expenses | 0.4% | 942 | 938 | 905 | 899 | 909 | 911 | 914 | 918 | 905 | 908 | 891 | 896 | 880 | 952 | 964 | 968 | 1,048 | 1,035 | 1,130 | 1,121 | 1,205 |
Earnings Before Taxes | -16.5% | 2,833 | 3,391 | 2,859 | 4,648 | 6,271 | 9,770 | 8,126 | 6,984 | 5,865 | 1,575 | 6,927 | 6,726 | 8,594 | 10,694 | 6,795 | 9,303 | 7,591 | 6,395 | 6,307 | 4,797 | 4,203 |
EBT Margin | -100.0% | - | 0.03* | 0.04* | 0.03* | 0.06* | 0.12* | 0.11* | 0.10* | 0.08* | 0.02* | 0.10* | 0.10* | 0.13* | 0.15* | 0.10* | - | - | - | - | - | - |
Net Income | -18.6% | 2,225 | 2,733 | 2,539 | 4,149 | 5,338 | 7,835 | 6,554 | 5,512 | 4,634 | 1,372 | 5,410 | 5,845 | 7,323 | 8,919 | 5,899 | 7,373 | 6,101 | 5,251 | 5,123 | 5,373 | 4,370 |
Net Income Margin | -100.0% | - | 0.03* | 0.04* | 0.03* | 0.05* | 0.10* | 0.09* | 0.08* | 0.07* | 0.02* | 0.08* | 0.09* | 0.11* | 0.12* | 0.08* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 13,190 | 13,204 | 16,010 | 15,238 | 13,054 | 12,596 | 12,409 | 12,696 | 11,288 | 11,639 | 11,667 | 12,020 | 13,561 | 13,786 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 0.4% | 677,279 | 674,266 | 663,072 | 650,104 | 662,893 | 724,284 | 759,708 | 761,664 | 773,253 | 769,814 | 795,146 | 780,492 | 767,583 | 737,741 | 740,463 | 742,812 | 732,167 | 713,188 | 687,538 | 698,451 | 706,333 |
Cash Equivalents | -16.5% | 15,417 | 18,456 | 20,195 | 22,200 | 20,548 | 23,488 | 20,047 | 18,956 | 25,037 | 19,635 | 19,795 | 24,405 | 24,289 | 24,094 | 16,598 | 19,452 | 18,435 | 14,506 | 15,821 | 12,490 | 16,312 |
Goodwill | -1.3% | 9,261 | 9,379 | 9,297 | 9,005 | 9,151 | 9,510 | 9,535 | 9,638 | 9,768 | 9,944 | 10,112 | 9,360 | 9,245 | 9,159 | 9,308 | 9,278 | 9,408 | 9,418 | 9,422 | 9,440 | 9,499 |
Liabilities | 0.8% | 646,787 | 641,843 | 632,947 | 624,774 | 625,526 | 670,047 | 691,959 | 692,331 | 703,830 | 703,677 | 720,329 | 706,923 | 691,643 | 667,278 | 674,081 | 674,193 | 668,121 | 654,450 | 634,580 | 646,642 | 652,501 |
Short Term Borrowings | 19.0% | 200 | 168 | 175 | 183 | 196 | 323 | 341 | 346 | 393 | 302 | 393 | 351 | 303 | 298 | 235 | 142 | 158 | 289 | 268 | 290 | 479 |
Shareholder's Equity | -6.7% | 30,261 | 32,423 | 29,881 | 25,076 | 34,009 | 42,703 | 50,013 | 69,333 | 69,423 | 66,137 | 74,817 | 73,569 | 75,940 | 70,463 | 66,382 | 68,619 | 64,046 | 58,738 | 52,958 | 51,809 | 53,832 |
Retained Earnings | -0.1% | 39,928 | 39,957 | 40,332 | 41,032 | 41,101 | 41,406 | 41,197 | 40,426 | 39,318 | 36,373 | 31,824 | 36,782 | 36,568 | 36,919 | 33,078 | 32,948 | 31,209 | 29,944 | 28,926 | 27,331 | 26,870 |
Additional Paid-In Capital | 0.0% | 33,630 | 33,617 | 33,616 | 33,589 | 33,548 | 33,531 | 33,511 | 33,457 | 33,440 | 33,910 | 33,812 | 33,744 | 33,728 | 33,711 | 32,680 | 32,639 | 32,602 | 32,535 | 32,474 | 32,475 | 32,454 |
Shares Outstanding | -1.6% | 757 | 769 | 779 | 787 | 798 | 815 | 826 | 845 | 861 | 878 | 893 | 906 | 908 | 908 | 915 | 920 | 936 | 950 | 959 | 987 | 1,000 |
Minority Interest | 0.9% | 231 | 229 | 244 | 254 | 266 | 272 | 267 | 283 | 285 | 273 | 259 | 253 | 247 | 242 | 238 | 251 | 235 | 229 | 217 | 184 | 199 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -10.3% | 11,835 | 13,190 | 13,204 | 16,010 | 15,279 | 13,140 | 12,596 | 12,409 | 12,696 | 11,288 | 11,639 | 11,667 | 12,020 | 13,561 | 13,786 | 9,906 | 9,293 | 12,514 | 11,738 | 12,487 | 13,688 |
Cashflow From Investing | -228.8% | -12,159 | -3,698 | -2,620 | -5,285 | -9,453 | -10,559 | -11,187 | -10,487 | -8,886 | -11,286 | -18,569 | -23,500 | -22,172 | -20,224 | -17,586 | -5,135 | -6,012 | -10,848 | -5,634 | -10,710 | -14,491 |
Cashflow From Financing | 66.4% | -4,801 | -14,268 | -10,108 | -6,742 | -9,666 | 1,054 | -1,375 | -7,033 | -3,040 | -3,992 | 10,729 | 16,713 | 16,155 | 16,409 | 4,568 | 2,245 | -1,163 | -703 | -2,801 | -2,064 | -100 |
Dividend Payments | -0.6% | 1,581 | 1,590 | 1,598 | 1,610 | 1,623 | 1,636 | 1,647 | 1,657 | 1,663 | 1,661 | 1,657 | 1,648 | 1,642 | 1,642 | 1,643 | 1,652 | 1,658 | 1,667 | 1,678 | 1,685 | 1,693 |
Buy Backs | -14.0% | 2,722 | 3,166 | 3,326 | 3,906 | 4,247 | 4,244 | 4,303 | 3,698 | 2,763 | 1,650 | 1,151 | 830 | 1,535 | 2,285 | 2,285 | 3,235 | 3,086 | 3,451 | 3,992 | 3,414 | 3,273 |
Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2022 | Mar. 31, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues | ||||||
Premiums | $ 11,678 | $ 11,556 | $ 21,267 | $ 22,173 | ||
Universal life and investment-type product policy fees | 1,288 | 1,372 | 2,577 | 2,684 | ||
Net investment income | 5,072 | 3,583 | 9,717 | 7,867 | ||
Other revenues | 621 | 615 | 1,260 | 1,275 | ||
Net investment gains (losses) | (1,039) | (682) | (1,723) | (1,199) | ||
Net derivative gains (losses) | (997) | (970) | (1,087) | (1,921) | ||
Total revenues | 16,623 | 15,474 | 32,011 | 30,879 | ||
Expenses | ||||||
Policyholder benefits and claims | 11,809 | 11,615 | 21,681 | 22,789 | ||
Policyholder liability remeasurement (gains) losses | (16) | (1) | (25) | (42) | ||
Market risk benefit remeasurement (gains) losses | (817) | (757) | (629) | (2,197) | ||
Interest credited to policyholder account balances | 1,933 | 527 | 3,797 | 1,153 | ||
Policyholder dividends | 151 | 194 | 310 | 393 | ||
Other expenses | 3,133 | 2,908 | 6,190 | 5,860 | ||
Total expenses | 16,193 | 14,486 | 31,324 | 27,956 | ||
Income (loss) before provision for income tax | 430 | 988 | 687 | 2,923 | ||
Provision for income tax expense (benefit) | 22 | 73 | 194 | 369 | ||
Net income (loss) | 408 | $ 85 | 915 | $ 1,639 | 493 | 2,554 |
Less: Net income (loss) attributable to noncontrolling interests | 6 | 5 | 11 | 10 | ||
Net income (loss) attributable to MetLife, Inc. | 402 | 910 | 482 | 2,544 | ||
Less: Preferred stock dividends | 32 | $ 66 | 29 | $ 63 | 98 | 92 |
Net income (loss) available to MetLife, Inc.’s common shareholders | 370 | 881 | 384 | 2,452 | ||
Comprehensive income (loss) | (829) | (7,148) | 2,712 | (13,104) | ||
Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax | 8 | 4 | (5) | 7 | ||
Comprehensive income (loss) attributable to MetLife, Inc. | $ (837) | $ (7,152) | $ 2,717 | $ (13,111) | ||
Net income (loss) available to MetLife, Inc.’s common shareholders per common share: | ||||||
Basic | $ 0.48 | $ 1.09 | $ 0.50 | $ 3.00 | ||
Diluted | $ 0.48 | $ 1.08 | $ 0.50 | $ 2.98 |
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Investments: | ||
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $197 and $183, respectively); and amortized cost: $307,045 and $306,025, respectively | $ 283,857 | $ 276,780 |
Equity securities | 769 | 1,684 |
Contractholder-directed equity securities and fair value option securities, at estimated fair value | 10,204 | 9,668 |
Mortgage loans (net of allowance for credit loss of $724 and $527, respectively) | 92,986 | 83,763 |
Policy loans | 8,788 | 8,874 |
Real estate and real estate joint ventures (includes $310 and $299, respectively, under the fair value option) | 13,045 | 13,137 |
Other limited partnership interests | 14,722 | 14,414 |
Short-term investments, principally at estimated fair value | 6,921 | 4,935 |
Other invested assets (net of allowance for credit loss of $21 and $26, respectively; includes $2,088 and $1,926, respectively, of leveraged and direct financing leases; $338 and $326, respectively, relating to variable interest entities) | 19,656 | 20,038 |
Total investments | 450,948 | 433,293 |
Cash and cash equivalents, principally at estimated fair value | 15,417 | 20,195 |
Accrued investment income | 3,505 | 3,446 |
Premiums, reinsurance and other receivables | 18,530 | 17,364 |
Market risk benefits | 279 | 280 |
Deferred policy acquisition costs and value of business acquired | 19,850 | 19,653 |
Current income tax recoverable | 189 | 42 |
Deferred income tax asset | 2,377 | 2,439 |
Goodwill | 9,261 | 9,297 |
Other assets | 10,977 | 11,025 |
Separate account assets | 145,946 | 146,038 |
Total assets | 677,279 | 663,072 |
Liabilities | ||
Future policy benefits | 190,474 | 187,222 |
Policyholder account balances | 214,413 | 210,597 |
Market risk benefits | 3,259 | 3,763 |
Other policy-related balances | 19,642 | 18,424 |
Policyholder dividends payable | 366 | 387 |
Payables for collateral under securities loaned and other transactions | 18,806 | 20,937 |
Short-term debt | 200 | 175 |
Long-term debt | 14,539 | 14,647 |
Collateral financing arrangement | 675 | 716 |
Junior subordinated debt securities | 3,160 | 3,158 |
Deferred income tax liability | 752 | 950 |
Other liabilities | 34,555 | 25,933 |
Separate account liabilities | 145,946 | 146,038 |
Total liabilities | 646,787 | 632,947 |
Contingencies, Commitments and Guarantees (Note 18) | ||
MetLife, Inc.’s stockholders’ equity: | ||
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference | 0 | 0 |
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,191,608,802 and 1,189,831,471 shares issued, respectively; 757,210,115 and 779,098,414 shares outstanding, respectively | 12 | 12 |
Additional paid-in capital | 33,630 | 33,616 |
Retained earnings | 39,928 | 40,332 |
Treasury stock, at cost; 434,398,687 and 410,733,057 shares, respectively | (22,923) | (21,458) |
Accumulated other comprehensive income (loss) | (20,386) | (22,621) |
Total MetLife, Inc.’s stockholders’ equity | 30,261 | 29,881 |
Noncontrolling interests | 231 | 244 |
Total equity | 30,492 | 30,125 |
Total liabilities and equity | $ 677,279 | $ 663,072 |